Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain

TOKYO and CAMBRIDGE, Mass., Aug 22, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc.announced today that the humanized amyloid-beta(Aβ) monoclonal antibody “Leqembi®” (brand name, generic name: lecanemab) has been granted a Marketing Authorization by the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain.1 Lecanemab…

Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT)

SHANGHAI, Aug 22, 2024 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced the launch of an Investigator-Initiated Clinical Trial (IIT) for a personalized mRNA cancer vaccine, EVM16, under the…

MHI Begins Joint Demonstration with Kirin Group for Automation of Inbound and Outbound Warehouse Processes, and Loading and Unloading of Trucks

TOKYO, Aug 22, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI), together with Kirin Group companies Kirin Beverage Co., Ltd. and Kirin Group Logistics Co., Ltd., in August will begin a joint demonstration aimed at establishing elemental technologies for the automation of inbound and outbound processes…

DreamFolks Expands Footprint to SEAsian Market

SINGAPORE, Aug 20, 2024 - (ACN Newswire via SeaPRwire.com) - DreamFolks, India's largest airport services aggregator, is proud to announce its strategic expansion into the Southeast Asian market. This milestone marks a significant step in DreamFolks' mission to redefine travel experiences on a global scale.Over the past 12 years, DreamFolks…

California Healthcare Provider Expands Use of Knightscope Robots

MOUNTAIN VIEW, Calif., August 21, 2024–. [Nasdaq:KSCP] (“Knightscope” or the “Company”), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, today announces that a long standing healthcare client based in California has expanded its contract subscribing to another  (“ASR”). The client originally deployed their first K5 ASR…

Mounjaro Shows Promise in Preventing Type 2 Diabetes in Prediabetic Patients

Mounjaro, Eli Lilly's (NYSE:LLY) Type 2 diabetes medication, is demonstrating significant potential within the pharmaceutical industry. A series of successful clinical trials and robust market performance have positioned Mounjaro as a leading contender among currently available medications. Recent trial results, announced by Lilly on Tuesday, further solidify Mounjaro's promising profile,…